Requires the Comptroller General to assess wearable medical devices' use in clinical decision-making, focusing on their treatment-prescribing accuracy, AI's role in enhancing capabilities, and policy options to optimize benefits and address development challenges.
Analysis summaries, actor details, and coverage mappings were LLM-classified and may contain errors.
This is a binding legislative provision enacted by the United States Congress that mandates the Comptroller General to conduct a technology assessment and submit a report to Congress within a specified timeframe.
The document has minimal coverage of risk domains, with brief mentions of AI system safety (7.3 - lack of robustness) and human-computer interaction (5.1 - overreliance). The focus is on assessing capabilities and limitations rather than governing specific risks. Coverage is limited to 2-3 subdomains at minimal levels.
The document primarily governs the Health Care and Social Assistance sector through its focus on wearable medical devices used in clinical decision-making. It also has minimal coverage of Scientific Research and Development Services through the mandated technology assessment.
The document addresses multiple lifecycle stages with primary focus on deployment and operational monitoring of wearable medical devices. It covers the use of AI models in clinical settings, validation of treatment accuracy, and ongoing assessment of capabilities and limitations.
The document explicitly mentions artificial intelligence in the context of augmenting wearable medical device capabilities. It focuses on AI systems used in clinical decision-making but does not specify particular AI model types, compute thresholds, or distinguish between frontier, general purpose, or task-specific AI.
United States Congress
The document is Section 217 of the Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act 2025, which is enacted by the United States Congress as the legislative authority.
United States Congress
Congress has oversight authority over the Comptroller General and receives the mandated report, providing implicit enforcement through its legislative and oversight powers.
Comptroller General of the United States; Government Accountability Office
The Comptroller General is explicitly tasked with conducting the technology assessment and monitoring the capabilities and limitations of wearable medical devices.
Developers and users of wearable medical devices
The assessment targets wearable medical devices used in clinical decision-making, which would be developed by medical device manufacturers and deployed by healthcare providers.
2 subdomains (2 Minimal)